Ratings by Benchmark (Bruce Jackson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/19/2024 | Cardio Diagnostics Holdings, Inc. | CDIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/15/2024 | Tenon Medical Inc. | TNON | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/8/2024 | Know Labs | KNW | New Coverage | Speculative Buy (N/A) |
0.64 (0.62) |
-3.13% | Details | |
| 3/13/2024 | Tenon Medical Inc. | TNON | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 1/2/2024 | Exact Sciences | EXAS | Upgrade | Buy (Hold) |
73.98 (59.00) |
-20.25% | Details | |
| 11/15/2023 | Tenon Medical Inc. | TNON | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/14/2023 | The Beauty Health Company | SKIN | Downgrade | Hold (Buy) |
3.90 (3.08) |
-21.03% | Details | |
| 9/21/2023 | Seelos Therapeutics | SEEL | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 9/15/2023 | STAAR Surgical | STAA | Downgrade | Hold (Buy) |
42.87 (46.20) |
7.77% | Details | |
| 8/24/2023 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/9/2023 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Exact Sciences | EXAS | Downgrade | Hold (Buy) |
96.44 (73.98) |
-23.29% | Details | |
| 7/26/2023 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 7/21/2023 | CytoMed Therapeutics | GDTC | New Coverage | Speculative Buy (N/A) |
3.85 (2.15) |
-44.16% | Details | |
| 6/30/2023 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2023 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2023 | Reviva Pharmaceuticals | RVPH | New Coverage | Speculative Buy (N/A) |
7.16 (3.07) |
-57.12% | Details | |
| 5/10/2023 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2023 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2023 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/10/2023 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2023 | Seelos Therapeutics | SEEL | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/15/2023 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/10/2023 | Harvard Bioscience Inc. | HBIO | Upgrade | Buy (Speculative Buy) |
2.66 (3.58) |
34.59% | Details | |
| 2/24/2023 | Neogenomics | NEO | Upgrade | Buy (Hold) |
16.63 (13.71) |
-17.56% | Details | |
| 2/1/2023 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2023 | VolitionRX | VNRX | Downgrade | Hold (Buy) |
2.47 (0.84) |
-65.99% | Details | |
| 1/10/2023 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/23/2022 | Orgenesis | ORGS | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Hoth Therapeutics | HOTH | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/16/2022 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/10/2022 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/3/2022 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Cardio Diagnostics Holdings, Inc. | CDIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/26/2022 | Neogenomics | NEO | Downgrade | Hold (Buy) |
11.70 (13.71) |
17.18% | Details | |
| 8/11/2022 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Heart Test Laboratories Inc. | HSCS | New Coverage | Speculative Buy (N/A) |
2.12 (0.10) |
-95.28% | Details | |
| 8/3/2022 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2022 | Invitae Corporation | NVTA | Downgrade | Hold (Buy) |
2.67 (0.02) |
-99.25% | Details | |
| 6/21/2022 | Tenon Medical Inc. | TNON | New Coverage | Speculative Buy (N/A) |
2.16 (0.75) |
-65.28% | Details | |
| 5/27/2022 | Hoth Therapeutics | HOTH | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/17/2022 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/28/2022 | STAAR Surgical | STAA | Upgrade | Buy (Neutral) |
72.95 (46.20) |
-36.67% | Details | |
| 3/22/2022 | The Beauty Health Company | SKIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2022 | The Beauty Health Company | SKIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2021 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2021 | Invitae Corporation | NVTA | Upgrade | Buy (Hold) |
28.50 (0.02) |
-99.93% | Details | |
| 7/20/2021 | Alpha Healthcare Acquisition Corp. | AHAC | New Coverage | Buy (N/A) |
9.97 (10.96) |
9.93% | Details | |
| 6/28/2021 | The Beauty Health Company | SKIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2021 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2021 | Vesper Healthcare | VSPR | New Coverage | Buy (N/A) |
11.22 (12.49) |
11.32% | Details | |
| 3/17/2021 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/9/2021 | Seelos Therapeutics | SEEL | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2021 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2021 | STAAR Surgical | STAA | Downgrade | Hold (Buy) |
90.99 (46.20) |
-49.23% | Details | |
| 1/7/2021 | Harvard Bioscience Inc. | HBIO | Upgrade | Buy (Speculative Buy) |
4.27 (3.58) |
-16.16% | Details | |
| 1/7/2021 | OncoCyte Corp | OCX | Upgrade | Buy (Speculative Buy) |
2.53 (2.40) |
-5.14% | Details | |
| 7/1/2020 | Invitae Corporation | NVTA | Downgrade | Hold (Buy) |
30.29 (0.02) |
-99.93% | Details | |
| 6/17/2020 | Chembio Diagnostics | CEMI | Downgrade | Hold (Buy) |
9.93 (0.46) |
-95.37% | Details | |
| 4/2/2020 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2020 | LHC Group | LHCG | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | Chembio Diagnostics | CEMI | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 2/28/2020 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2019 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2019 | Harvard Bioscience Inc. | HBIO | Downgrade | Speculative Sell (Buy) |
2.94 (3.58) |
21.77% | Details | |
| 11/20/2019 | Biofrontera AG | BFRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2019 | Hoth Therapeutics | HOTH | New Coverage | Speculative Buy (N/A) |
4.24 (1.16) |
-72.64% | Details | |
| 9/26/2019 | Orgenesis | ORGS | New Coverage | Speculative Sell (N/A) |
4.20 (0.51) |
-87.86% | Details | |
| 9/23/2019 | Exact Sciences | EXAS | Upgrade | Buy (Hold) |
103.97 (59.00) |
-43.25% | Details | |
| 7/31/2019 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2019 | Flexion Therapeutics | FLXN | Upgrade | Buy (Hold) |
10.24 (9.12) |
-10.94% | Details | |
| 1/4/2019 | Flexion Therapeutics | FLXN | Downgrade | Hold (Buy) |
12.46 (10.24) |
-17.82% | Details | |
| 11/1/2018 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2018 | Exact Sciences | EXAS | New Coverage | Hold (N/A) |
77.60 (103.97) |
33.98% | Details |
